Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma

Carboxylesterase 2 (CES2) is instrumental for conversion of ester-containing prodrugs in cancer treatment. Novel treatment strategies are exceedingly needed for cholangiocarcinoma (CCA) patients. Here, we assessed CES2 expression by immunohistochemistry in a CCA cohort comprising 171 non-liver fluke...

Descripción completa

Detalles Bibliográficos
Autores principales: Goeppert, Benjamin, Renner, Marcus, Singer, Stephan, Albrecht, Thomas, Zhang, Qiangnu, Mehrabi, Arianeb, Pathil, Anita, Springfeld, Christoph, Köhler, Bruno, Rupp, Christian, Weiss, Karl Heinz, Kühl, Anja A., Arsenic, Ruza, Pape, Ulrich Frank, Vogel, Arndt, Schirmacher, Peter, Roessler, Stephanie, Utku, Nalân
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416336/
https://www.ncbi.nlm.nih.gov/pubmed/30867471
http://dx.doi.org/10.1038/s41598-019-40487-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416336/
https://www.ncbi.nlm.nih.gov/pubmed/30867471
http://dx.doi.org/10.1038/s41598-019-40487-9

Ejemplares similares